Menek Goldstein

Q: What Schools Are Affiliated With Menek Goldstein

Menek Goldstein is affiliated with the following schools: New York University, Karolinska Institute

Menek Goldstein's AcademicInfluence.com Rankings

Menek Goldstein

Biology

#2912

World Rank

#4542

Historical Rank

Neuroscience

#256

World Rank

#270

Historical Rank

biology Degrees

Download Badge

Biology

Menek Goldstein's Degrees

PhD Neuroscience Stanford University

Why Is Menek Goldstein Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Menek Goldstein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. (1982) (1200)
Immunohistochemical evidence for the existence of adrenaline neurons in the rat brain (1974) (1072)
Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat (1984) (853)
Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system (1978) (811)
A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunohistochemistry combined with retrograde tracing (1980) (704)
Evidence for coexistence of dopamine and CCK in meso-limbic neurones (1980) (686)
High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man (1983) (617)
Enkephalin-like immunoreactivity in gland cells and nerve terminals of the adrenal medulla (1978) (544)
Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress. (1989) (533)
Coexistence of galanin-like immunoreactivity with catecholamines, 5- hydroxytryptamine, GABA and neuropeptides in the rat CNS (1986) (517)
Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. (1986) (466)
Occurrence of somatostatin-like immunoreactivity in some peripheral sympathetic noradrenergic neurons. (1977) (450)
Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons (1984) (443)
NADPH‐diaphorase: A selective histochemical marker for striatal neurons containing both somatostatin‐ and avian pancreatic polypeptide (APP)‐like immunoreactivities (1983) (431)
Chemical anatomy of the brain. (1984) (410)
Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus (1988) (362)
Rat medulla oblongata. II. Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal processes (1985) (362)
Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. (1981) (356)
On the occurrence of substance P-containing fibers in sympathetic ganglia: Immunohistochemical evidence (1977) (353)
Enkephalin immunoreactive nerve fibres and cell bodies in sympathetic ganglia of the guinea-pig and rat (1979) (341)
Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain II. Tyrosine hydroxylase in the telencephalon. (1977) (319)
Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons (1981) (318)
The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific (1987) (306)
Inhibition of dopamine- β -hydroxylase by disulfiram (1964) (278)
Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line. (1980) (267)
Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat vas deferens (1985) (260)
Aminergic and peptidergic pathways in the nervous system with special reference to the hypothalamus. (1978) (252)
Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. (1990) (246)
Neuropeptide Y (NPY)- and FMRFamide neuropeptide-like immunoreactivities in catecholamine neurons of the rat medulla oblongata. (1983) (243)
Organizational principles in the peripheral sympathetic nervous system: subdivision by coexisting peptides (somatostatin-, avian pancreatic polypeptide-, and vasoactive intestinal polypeptide-like immunoreactive materials). (1982) (238)
The hypothalamic arcuate nucleus-median eminence complex: Immunohistochemistry of transmitters, peptides and DARPP-32 with special reference to coexistence in dopamine neurons (1986) (235)
Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. (1988) (227)
Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting. (1983) (224)
Evidence for adrenaline neurons in the rat brain. (1973) (220)
Enkephalin- and somatostatin-like immunoreactivities in human adrenal medulla and pheochromocytoma. (1979) (219)
Ontogenetic appearance and disappearance of tyrosine hydroxylase and catecholamines in the rat embryo. (1978) (217)
Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase (1983) (214)
Rat medulla oblongata. III. Adrenergic (C1 and C2) neurons, nerve fibers and presumptive terminal processes (1985) (206)
Immunohistochemical evidence of vasoactive intestinal polypeptide-containing neurons and nerve fibers in sympathetic ganglia (1977) (206)
Coexistence of an avian pancreatic polypeptide (APP) immunoreactive substance and catecholamine in some peripheral and central neurons. (1980) (203)
Chapter 4 Coexistence of neuronal messengers — an overview (1986) (202)
Transmitter histochemistry of the rat olfactory bulb. I. Immunohistochemical localization of monoamine synthesizing enzymes. Support for intrabulbar, periglomerular dopamine neurons (1977) (199)
Evidence for an inhibitory effect of the peptide galanin on dopamine release from the rat median eminence (1987) (197)
Calcium/phospholipid-dependent protein kinase (protein kinase C) phosphorylates and activates tyrosine hydroxylase. (1984) (195)
Origin of peptide-containing fibers in the inferior mesenteric ganglion of the guinea-pig: Immunohistochemical studies with antisera to substance P, enkephalin, vasoactive intestinal polypeptide, cholecystokinin and bombesin (1983) (194)
Effects of ibotenic acid-induced neuronal degeneration in the medial preoptic area and the lateral hypothalamic area on sexual behavior in the male rat (1982) (193)
Distribution of substance P-like immunoreactivity in the central nervous system of the rat—II. Light microscopic localization in relation to catecholamine-containing neurons (1978) (191)
Presence of avian pancreatic polypeptide-like immunoreactivity in catecholamine and methionine-enkephalin-containing neurones within the central nervous system (1981) (190)
Effect of insulin on central catecholamines (1983) (189)
Characterization and tissue localization of catecholamine synthesizing enzymes. (1972) (185)
VIP-, enkephalin-, substance P- and somatostatin-like immunoreactivity in neurons intrinsic to the intestine: immunohistochemical evidence from organotypic tissue cultures (1978) (179)
Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine. (1974) (178)
Distribution of tyrosine‐hydroxylase‐immunoreactive neurons in the hypothalamus of rats (1984) (175)
Evidence for a dopaminergic pathway in the rat descending from the A11 cell group to the spinal cord. (1979) (174)
Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata (1983) (174)
The effect of disulfiram on catecholamine levels in the brain. (1967) (171)
Peptide neurons in peripheral tissues including the urinary tract: immunohistochemical studies. (2009) (168)
Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. (1975) (157)
Expression of catecholaminergic characteristics by primary sensory neurons in the normal adult rat in vivo. (1983) (154)
Initial development of the noradrenergic phenotype in autonomic neuroblasts of the rat embryo in vivo. (1979) (152)
Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: evidence for functional reinnervation (1986) (152)
Do tyrosine hydroxylase-immunoreactive neurons in the ventrolateral arcuate nucleus produce dopamine or only L-dopa? (1988) (151)
Role of glucocorticoids in expression of the adrenergic phenotype in rat embryonic adrenal gland. (1981) (148)
Dopaminergic mechanisms in the pathogenesis of schizophrenia 1 (1992) (148)
Dopamine D1 Receptor‐mediated Facilitation of GABAergic Neurotransmission in the Rat Strioentopeduncular Pathway and its Modulation by Adenosine A1 Receptor‐mediated Mechanisms (1996) (145)
Increase of corticotropin-releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline (1984) (145)
Immunohistochemical localization of aromatic L-amino acid decarboxylase (DOPA decarboxylase) in central dopamine and 5-hydroxytryptamine nerve cell bodies of the rat. (1973) (142)
Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. (1991) (142)
Proximal tubule Na+-K+-ATPase activity is inhibited during high-salt diet: evidence for DA-mediated effect. (1988) (142)
Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. (1991) (141)
Ibotenic acid-induced neuronal degeneration: A morphological and neurochemical study (1979) (140)
Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients (1986) (140)
Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics. (1985) (139)
Interaction of pergolide with central dopaminergic receptors. (1980) (136)
Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain. I. Tyrosine hydroxylase in the mes- and diencephalon. (1976) (136)
The dopaminergic innervation of monkey prefrontal cortex: a tyrosine hydroxylase immunohistochemical study (1988) (134)
Relationship between receptor occupancy and response at striatal dopamine autoreceptors. (1987) (134)
INHIBITION OF DOPAMINE-β-HYDROXYLASE BY DISULFIRAM IN VIVO (1966) (132)
A subpopulation of dopaminergic neurons in rat ventral mesencephalon contains both neurotensin and cholecystokinin (1988) (131)
Appearance of the noradrenergic markers tyrosine hydroxylase and neuropeptide Y in cholinergic nerves of the iris following sympathectomy (1985) (130)
Development of a dopamine- and cyclic adenosine 3':5'-monophosphate- regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation (1987) (127)
Immunohistochemical studies on monoamine-containing cell systems. (1973) (126)
Morphometrical analysis of the distribution of corticotrophin releasing factor, glucocorticoid receptor and phenylethanolamine-N-methyltransferase immunoreactive structures in the paraventricular hypothalamic nucleus of the rat (1985) (124)
Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease (1994) (122)
Fluorescence microscopical, immunohistochemical and ultrastructural studies on sympathetic ganglia of the guinea pig, with special reference to the sif cells and their catecholamine content. (1975) (120)
APPLICATIONS OF IMMUNOHISTOCHEMISTRY TO STUDIES ON MONOAMINE CELL SYSTEMS WITH SPECIAL REFERENCE TO NERVOUS TISSUES * (1975) (120)
Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection (1988) (119)
Dopaminergic Systems in the Brain and Pituitary (1985) (118)
Localization and characterization of phenylethanolamine N-methyl transferase in the brain of various mammalian species (1977) (116)
STUDIES OF AMINES IN THE STRIATUM IN MONKEYS WITH NIGRAL LESIONS (1969) (115)
Ergot compounds and brain function : neuroendocrine and neuropsychiatric aspects (1980) (113)
Phencyclidine- and Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated (1994) (113)
Immunohistochemical identification of two types of dopamine neuron in the rat olfactory bulb as seen by serial sectioning (1981) (111)
Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist. (1985) (107)
Cellular Localization of Dopamine-β-hydroxylase and Phenylethanolamine-N-methyl Transferase as Revealed by Immunohistochemistry (1971) (107)
Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease. (1971) (106)
Retrograde peroxidase tracing of neurons combined with transmitter histochemistry (1975) (106)
Isolation and characterization of multiple forms of phenylethanolamine N-methyltransferase. (1973) (104)
Coexistence of tyrosine hydroxylase-like and gamma-aminobutyric acid-like immunoreactivities in neurons of the arcuate nucleus. (1984) (104)
Distribution of Cholecystokinin‐like Immunoreactivity in the Nervous System (1985) (102)
Stimulation of tyrosine hydroxylase activity by cyclic amp in synaptosomes and in soluble striatal enzyme preparations (1976) (102)
A method for specific transmitter identification of retrogradely labeled neurons: Immunofluorescence combined with fluorescence tracing (1984) (101)
Topography of NPY-, somatostatin-, and VIP-immunoreactive, neuronal subpopulations in the guinea pig celiac-superior mesenteric ganglion and their projection to the pylorus (1986) (101)
Neurotensin-like immunoreactivity in the preganglionic sympathetic nerves and in the adrenal medulla of the cat. (1982) (100)
Coexistence and gene expression of phenylethanolamine N-methyltransferase, tyrosine hydroxylase, and neuropeptide tyrosine in the rat and bovine adrenal gland: effects of reserpine. (1988) (100)
Kinetic studies of the enzymatic dopamine beta-hydroxylation reaction. (1968) (100)
Transient expression of selected catecholaminergic traits in cranial sensory and dorsal root ganglia of the embryonic rat. (1984) (99)
Changes in Human Serum Dopamine-β-Hydroxylase Activity with Age (1972) (98)
Morphometrical and microdensitometrical studies on phenylethanolamine-N-methyltransferase- and neuropeptide Y-immunoreactive neurons in the rostral medulla oblongata of the adult and old male rat (1988) (98)
STUDIES ON THE PURIFICATION AND CHARACTERIZATION OF 3,4-DIHYDROXYPHENYLETHYLAMINE BETA-HYDROXYLASE. (1965) (97)
The conversion in vivo of D-amphetamine to (+)-p-hydroxynorephedrine. (1965) (95)
The inhibition of catecholamine biosynthesis by apomorphine (1970) (93)
Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors. (1993) (92)
Dopamine and cholecystokinin immunoreactive neurones in mesencephalic grafts reinnervating the neostriatum: Evidence for selective growth regulation (1984) (92)
Immunohistochemical evidence for a "neurotoxic" action of (D-Pro2, D-Trp7,9)-substance P, an analogue with substance P antagonistic activity. (1981) (91)
Neuropeptide Y and galanin in norepinephrine release in hypothalamic slices. (1989) (90)
Effects of piperoxane on sleep and waking in the rat. Evidence for increased waking by blocking inhibitory adrenaline receptors on the locus coeruleus. (1974) (89)
Receptor autoradiographical evidence for high densities of 125I-neuropeptide Y binding sites in the nucleus tractus solitarius of the normal male rat. (1986) (88)
Localization of choline acetyltransferase in rat peripheral sympathetic neurons and its coexistence with nitric oxide synthase and neuropeptides. (1995) (87)
Studies on neuropeptide Y-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Relationship to neuroendocrine function (1986) (86)
Basic FGF is present in dopaminergic neurons of the ventral midbrain of the rat. (1991) (86)
Immunohistochemical localization of dopamine- -hydroxylase in the peripheral and central nervous system. (1970) (85)
DARPP-32, a dopamine- and cyclic AMP-regulated phosphoprotein in tanycytes of the mediobasal hypothalamus: Distribution and relation to dopamine and luteinizing hormone-releasing hormone neurons and other glial elements (1988) (83)
Cellular localization of peptides in neural structures (1980) (81)
Treatment of parkinson's disease with bromocriptine. (1976) (81)
1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons (1986) (80)
'Neuropeptide tyrosine' (NPY) is co-stored with noradrenaline in vascular but not in parenchymal sympathetic nerves of brown adipose tissue. (1986) (79)
The effect of trivastal, haloperidol and dibutyryl cyclic AMP on [14C]dopamine synthesis in rat striatum (1973) (78)
9 – Immunocytochemical Localization of Noradrenaline, Adrenaline and Serotonin (1983) (78)
Stoichiometry of Tyrosine Hydroxylase Phosphorylation in the Nigrostriatal and Mesolimbic Systems In Vivo (2000) (77)
Expression of phenylethanolamine N-methyltransferase in rat sympathetic ganglia and extra-adrenal chromaffin tissue. (1982) (76)
Substance K and substance P differentially modulate mesolimbic and mesocortical systems (1985) (76)
Neuropeptide tyrosine in the rat adrenal gland—immunohistochemical and in situ hybridization studies (1988) (76)
Dense plexus of substance P immunoreactive nerve terminals in eminentia medialis of the primate hypothalamus. (1978) (75)
Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion (2004) (74)
Immunohistochemical evidence for a new group of catecholamine-containing neurons in the basal forebrain of the monkey (1983) (74)
Relationship of catecholamines and LHRH: Light microscopic study (1982) (73)
Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists. (1986) (73)
Effects of 6-hydroxydopamine lesions of the prefrontal cortex on tyrosine hydroxylase activity in mesolimbic and nigrostriatal dopamine systems (1992) (73)
Dopaminergic transmission in the rat retina: evidence for volume transmission (1996) (73)
Bromocriptine in Parkinson disease. (1985) (73)
Cell-free detection and characterization of a novel nerve growth factor-activated protein kinase in PC12 cells. (1987) (71)
Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (1986) (71)
Analysis of expression of cholecystokinin in dopamine cells in the ventral mesencephalon of several species and in humans with schizophrenia. (1990) (71)
Regulation of l‐DOPA Biosynthesis by Site‐Specific Phosphorylation of Tyrosine Hydroxylase in AtT‐20 Cells Expressing Wild‐Type and Serine 40‐Substituted Enzyme (1996) (70)
Tyrosine hydroxylase immunohistochemistry in human brain (1979) (70)
Centrally administered endothelin-1 produces lesions in the brain of the male rat. (1989) (69)
The substrate specificity of phenylamine-beta-hydroxylase. (1962) (69)
Distribution of catecholamine-containing neurons in the normal human hypothalamus (1985) (69)
Dopamine agonist induced self-multilative biting behavior in monkeys with unilateral ventromedial tegmental lesions of the brainstem: Possible pharmacological model for Lesch-Nyhan syndrome (1986) (69)
Activation of the locus coeruleus induced by selective stimulation of the ventral tegmental area (1986) (68)
Studies on the antiparkinsonian efficacy of lergotrile (1975) (68)
Selective loss of noradrenergic phenotypic characters in neuroblasts of the rat embryo. (1979) (66)
Striato-nigral dynorphin and substance P pathways in the rat (1986) (66)
Studies on dopamine-, tyrosine hydroxylase-and aromatic l-amino acid decar☐ylase-containing cells in the rat diencephalon: Comparison between formaldehyde-induced histofluorescence and immunofluorescence (1988) (66)
Coexistence of tyrosine hydroxylase and growth hormone-releasing factor in a subpopulation of tubero-infundibular neurons of the rat. (1986) (64)
Role of Serine‐19 Phosphorylation in Regulating Tyrosine Hydroxylase Studied with Site‐ and Phosphospecific Antibodies and Site‐Directed Mutagenesis (1998) (64)
Aspects on the information handling by the central nervous system: focus on cotransmission in the aged rat brain. (1986) (63)
Morphofunctional studies on the neuropeptide Y/adrenaline costoring terminal systems in the dorsal cardiovascular region of the medulla oblongata. Focus on receptor-receptor interactions in cotransmission. (1986) (63)
Presence of NADPH-cytochrome P450 reductase in central catecholaminergic neurones (1984) (63)
Effect of intranigral injections of dynorphin, dynorphin fragments and alpha-neoendorphin on rotational behaviour in the rat. (1984) (63)
On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat (1999) (63)
Immunohistochemical evidence for phenylethanolamine-N-methyltransferase-positive/tyrosine hydroxylase-negative neurones in the retina and the posterior hypothalamus of the rat (1985) (63)
Immunohistochemistry of tyrosine hydroxylase and phenylethanolamine N-methyltransferase in the human brain stem: Description of adrenergic perikarya and characterization of longitudinal catecholaminergic pathways (1988) (62)
Effect of stress and of phenylethanolamine-N-methyltransferase inhibition on central norepinephrine and epinephrine levels (1978) (62)
Enzymes Involved in the Catalysis of Catecholamine Biosynthesis (1972) (61)
Regulation of Tyrosine Hydroxylase Activity and Phosphorylation at Ser19 and Ser40 via Activation of Glutamate NMDA Receptors in Rat Striatum (2000) (60)
Adrenergic innervation and neurogenic response in large and small arteries and veins from the rat. (1986) (59)
Studies on the role of dopamine in cardiovascular and respiratory control: central versus peripheral mechanisms. (1977) (59)
Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse (1992) (59)
Ontogeny of phenylethanolamine N‐methyltransferase‐ and tyrosine hydroxylase‐like immunoreactivity in presumptive adrenaline neurones of the foetal rat central nervous system (1985) (59)
Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. (1988) (59)
F. INHIBITION OF NOREPINEPHRINE BIOSYNTHESIS AT THE DOPAMINE-β-HYDROXYLATION STAGE (1966) (58)
Calcitonin gene-related peptide and chromogranin a: Presence and intra-axonal transport in lumbar motor neurons in the rat, a comparison with synaptic vesicle antigens in immunohistochemical studies (1989) (58)
Histochemical support for a dopaminergic mechanism in the dendrites of certain periglomerular cells in the rat olfactory bulb (1975) (57)
The cholinergic innervation of the adrenal gland and its relation to enkephalin and nitric oxide synthase (1995) (57)
Mechanism of biosynthesis of soluble and membrane-bound forms of dopamine beta-hydroxylase in PC12 pheochromocytoma cells. (1983) (56)
Studies on neurotensin catecholamine interactions in the hypothalamus and in the forebrain of the male rat (1984) (55)
Distribution of glutamic acid decarboxylase messenger RNA-containing nerve cell populations of the male rat brain. (1990) (55)
Immunohistochemical and biochemical study on the development of the noradrenaline- and adrenaline-storing cells of the adrenal medulla of the rat (2004) (54)
The Dopaminergic System (1985) (54)
Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine. (1988) (53)
Evidence for the existence of putative dopamine-, adrenaline- and noradrenaline-containing vagal motor neurons in the brainstem of the rat (1984) (53)
Tyrosine 3-hydroxylase in rat brain and adrenal medulla: hybridization histochemistry and immunohistochemistry combined with retrograde tracing. (1986) (53)
The effects of ventromedial tegmental lesions on the biosynthesis of catecholamines in the striatum (1966) (52)
Stimulation of pre- and postsynaptic dopamine receptors by an ergoline and by a partial ergoline (1981) (51)
Effect of phenylethanolamine N-methyltransferase and dopamine-beta-hydroxylase inhibition on epinephrine levels in the brain. (1977) (51)
Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade (1987) (50)
Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity. (1988) (50)
Catecholamine turnover changes in hypothalamus and dorsal midline area of the caudal medulla oblongata of spontaneously hypertensive rats (1979) (50)
MAGNETIC RESONANCE STUDIES ON THE MECHANISM OF THE ENZYMIC BETA-HYDROXYLATION OF 3,4-DIHYDROXYPHENYLETHYLAMINE. (1965) (50)
Serum dopamine-beta-hydroxylase activity in neuroblastoma. (1972) (49)
Tyrosine hydroxylase and 28K-vitamin D-dependent calcium binding protein are localized in different subpopulations of periglomerular cells of the rat olfactory bulb (1985) (49)
Appearance of tyrosine hydroxylase immunoreactivity in the human embryo. (1980) (49)
Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity. (1999) (48)
Ontogeny of the dopamine and cyclic adenosine-3′: 5′ -monophosphate-regulated phosphoprotein (DARPP-32) in the pre- and postnatal mouse central nervous system (1988) (48)
The effect of neuropeptide Y (NPY) on stimulation-evoked release of [3H]norepinephrine (NE) from rat hypothalamic and cerebral cortical slices. (1987) (47)
Rapid increase in enzyme and peptide mRNA in sympathetic ganglia after electrical stimulation in humans. (1989) (47)
Effects of galanin on dopamine release in the central nervous system of normotensive and spontaneously hypertensive rats. (1998) (47)
Effect of dibutyryl cyclic adenosine monophosphate on 14C-dopamine biosynthesis in rat brain striatal slices. (1974) (47)
Immunohistochemical localization of three catecholamine synthesizing enzymes: aspects on methodology (1972) (46)
Regulation of tyrosine hydroxylase phosphorylation in PC12 pheochromocytoma cells by elevated K+ and nerve growth factor. Evidence for different mechanisms of action. (1985) (46)
Binding interactions of ergot alkaloids with monoaminergic receptors in the brain. (1978) (45)
Recovery of alpha 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). (1985) (45)
Purification of tyrosine hydroxylase from pheochromocytoma tumors. (1976) (45)
Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL/6 mice (1988) (45)
Glutamate-like immunoreactivity in medulla oblongata catecholamine/substance P neurons. (1990) (44)
Evidence for Cholecystokinin‐Dopamine Receptor Interactions in the Central Nervous System of the Adult and Old Rat (1985) (43)
Effects of Chronic Striatal Kainate Lesions on Some Dopaminergic Parameters and Enkephalin Immunoreactive Neurons in the Basal Ganglia (1980) (43)
Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis. (1992) (42)
Modulation of norepinephrine release by galanin in rat medulla oblongata. (1992) (42)
Evidence for a fast receptor turnover of D1 dopamine receptors in various forebrain regions of the rat (1987) (42)
A radioimmunoassay of human circulatory dopamine-β-hydroxylase☆ (1973) (41)
The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy. (1982) (41)
Norepinephrine Release and Neuropeptide Y in Medulla Oblongata of Spontaneously Hypertensive Rats (1990) (41)
Dopamine- -hydroxylase activity in mouse neuroblastoma tumors and in cell cultures. (1972) (41)
Localization of tyrosine hydroxylase immunoreactive neurons in the cat hypothalamus, with special reference to fluorescence histochemistry (1987) (41)
Somatostatin-like immunoreactivity in rat main olfactory bulb: extent of coexistence with neuropeptide Y-, tyrosine hydroxylase- and vitamin D-dependent calcium binding protein-like immunoreactivities (1989) (41)
The formation of 3, 4-dihydroxyphenylethanol and 3-methoxy-4-hydroxyphenylethanol from 3, 4-dihydroxy-phenylethylamine in the rat. (1961) (41)
Dopaminergic involvement in hypothalamic function: extrahypothalamic and hypothalamic control. A neuroanatomical analysis. (1974) (40)
Resistance of central phenylethanolamine-n-methyl transferase containing neurons to 6-hydroxydopamine. (1976) (40)
Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease. (1983) (40)
PERGOLIDE AND LISURIDE FOR PARKINSON'S DISEASE (1979) (40)
Dopaminephilic properties of ergot alkaloids. (1978) (40)
HISTOCHEMICAL IDENTIFICATION OF ADRENALINE CONTAINING CELLS WITH SPECIAL REFERENCE TO NEURONS (1980) (39)
Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry (2004) (39)
SERUM DOPAMINE-β-HYDROXYLASE ACTIVITY IN PATIENTS WITH HUNTINGTON'S CHOREA AND PARKINSON'S DISEASE (1972) (39)
INHIBITION OF DOPAMINE-BETA-HYDROXYLASE BY DISULFIRAM. (1964) (39)
Expression and development of phenylethanolamine N-methyltransferase (PNMT) in rat brain stem: studies with glucocorticoids. (1986) (39)
Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons (2004) (39)
Tyrosine hydroxylase immunoreactivity in familial dysautonomia. (1979) (38)
Selective expression of high-affinity uptake of catecholamines by transiently catecholaminergic cells of the rat embryo: studies in vivo and in vitro. (1985) (38)
Growth hormone releasing factor (GRF) and dopamine coexist in hypothalamic arcuate neurons. (1985) (38)
Morphometrical and microdensitometrical studies on phenylethanolamine-N-methyltransferase- and neuropeptide Y-immunoreactive nerve terminals and on glucocorticoid receptor-immunoreactive nerve cell nuclei in the paraventricular hypothalamic nucleus in adult and old male rats (1988) (38)
3-Acetylpyridine-induced degeneration of the nigrostriatal dopamine system: An animal model of olivopontocerebellar atrophy-associated parkinsonism (1989) (38)
N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a new tool to probe CNS receptor function. (1988) (37)
Coexistence of TRH with other neuroactive substances in the rat central nervous system. (1988) (37)
The inhibitionof dopamine-β-hydroxylase by tropolone and other chelating agents (1964) (37)
The effect of disulfiram on the biosynthesis of catecholamines during exposure of rats to cold. (1966) (37)
The effect of acute and chronic swim stress on dopamine-β-hydroxylase activity (1973) (37)
Further analysis of presence of peptides in dopamine neurons (1988) (37)
Receptor reserve at the alpha-2 adrenergic receptor in the rat cerebral cortex. (1987) (36)
Simultaneous expression of the SP-peptidergic and noradrenergic phenotypes in rat sympathetic neurons (1984) (36)
Solubilization of the neuroleptic binding receptor from rat striatum. (1981) (36)
Protective effects of chronic nicotine treatment on lesioned nigrostriatal dopamine neurons in the male rat. (1989) (35)
Substance P, VIP, enkephalin and somatostatin immunoreactive neurons in intestinal tissue transplanted to the anterior eye chamber. (1980) (35)
The ascending projections of the dopaminergic neurons of the substantia nigra, zona reticulata: a combined retrograde tracer-immunohistochemical study (1986) (35)
Dopamine neurons in the olfactory bulb. (1977) (34)
The effect of ouabain on catecholamine biosynthesis in rat brain cortex slices. (1970) (34)
Inhibition of serotonin synthesis by dopa and other catechols. (1971) (34)
The effects of centrally acting drugs on tremor in monkeys with mesencephalic lesions. (1969) (34)
Most ganglion cells in the rat adrenal medulla are noradrenergic. (1990) (34)
CHARACTERISATION, LOCALISATION AND REGULATION OF CATECHOLAMINE SYNTHESIZING ENZYMES (1973) (34)
Serum dopamine‐β‐hydroxylase levels in Down's syndrome (1974) (33)
A comparison of psychotomimetic drug effects on rat brain norepinephrine metabolism. (1974) (33)
Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo. (1966) (33)
Elevation of maternal glucocorticoid hormones alters neurotransmitter phenotypic expression in embryos. (1981) (33)
Cholecystokinin Neuron Systems and Their Interactions with the Presynaptic Features of the Dopamine Neuron Systems (1985) (33)
Metabolic pathways of 3-hydroxytyramine. (1959) (33)
The glucocorticoid receptor in the adrenal gland is localized in the cytoplasm of adrenaline cells. (1989) (32)
Evidence for a protective action of the vigilance promoting drug Modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis (2005) (32)
Solubilization and Characterization of Striatal Dopamine Receptors (1984) (32)
A monoclonal antibody against tyrosine hydroxylase: application in light and electron microscopy. (1986) (32)
The blockade of α2-adrenoceptors by the PNMT inhibitor SK&F 64139 (1980) (32)
GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. (1988) (31)
Studies on the relationship of tyrosine hydroxylase, dopamine and cyclic amp-regulated phosphoprotein-32 immunoreactive neuronal structures and d1 receptor antagonist binding sites in various brain regions of the male rat—mismatches indicate a role of d1 receptors in volume transmission (1988) (31)
Evidence for the existence of angiotensin II like immunoreactivity in subpopulations of tyrosine hydroxylase immunoreactive neurons in the A1 and C1 area of the ventral medulla of the male rat (1990) (31)
Induction of c-fos immunoreactivity in tyrosine hydroxylase and phenylethanolamine-N-methyltransferase immunoreactive neurons of the medulla oblongata of the rat after phosphate-buffered saline load in the urethane-anaesthetized rat (1993) (31)
Regulation of the multiple forms of dopamine beta-hydroxylase by nerve growth factor, dexamethasone, and dibutyryl cyclic AMP in the PC12 pheochromocytoma cell line. (1983) (30)
Brainstem dopaminergic neurons project to monkey parietal cortex (1988) (30)
Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen (1986) (30)
Effect of centrally acting drugs on experimental torticollis in monkeys. (1976) (29)
Effects of lesions and ganglioside GM1 treatment on striatal polyamine levels and nigral DA neurons. A role of putrescine in the neurotropic activity of gangliosides. (1985) (29)
Immunofluorescence Mapping of Central Monoamine and Releasing Hormone (LRH) Systems1 (1975) (29)
Evidence for a modulation by neuropeptide Y of the alpha-2 adrenergic transmission line in central adrenaline synapses. New possibilities for treatment of hypertensive disorders. (1984) (29)
INHIBITION OF TYROSINE HYDROXYLASE BY 3-IODO-L-TYROSINE. (1965) (29)
Inhibition of norepinephrine biosynthesis at the dopamine-beta-hydroxylation stage. (1966) (28)
A possible molecular mechanism for the antiparkinsonian action of bromocriptine in combination with levodopa (1985) (28)
Development of catecholaminergic phenotypic characters in the mouse locus coeruleus in vivo and in culture. (1983) (28)
A method to measure the distribution pattern of specific nerve terminals in sampled regions. Studies on tyrosine hydroxylase LHRH, TRH and GIH immunofluorescence. (1977) (28)
Monoaminergic and Peptidergic Innervation of the Intermedio‐Lateral Horn of the Spinal Cord (1990) (28)
Modulation of [3H]dopamine release by neuropeptide Y in rat striatal slices. (1997) (28)
Morphometrical evidence for a complex organization of tyrosine hydroxylase-,enkephalin- and darpp-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum (1988) (27)
Chapter 22 Characterization of central neuropeptide Y receptor binding sites and possible interactions with α2-adrenoceptors (1986) (27)
The stereospecificity of the enzymatic amphetamine β-hydroxylation (1964) (27)
Differential ontogeny of three putative catecholamine cell types in the postnatal rat retina. (1985) (27)
DARPP-32 as a marker for D-1 dopaminoceptive cells in the rat brain: prenatal development and presence in glial elements (tanycytes) in the basal hypothalamus. (1988) (27)
Golgi‐like immunoperoxidase staining of dopamine neurons in the reticular formation of the rat brainstem using antibody to tyrosine‐hydroxylase (1984) (27)
Evidence for a selective reduction of adrenaline turnover in the dorsal midline area of the caudal medulla oblongata of young spontaneous hypertensive rats. (1979) (26)
The effects of ventromedial tegmental lesions on the disposition of dopamine in the caudate nucleus of the monkey. (1967) (26)
Dopaminergic periglomerular cells in the turtle olfactory bulb (1982) (26)
COLLABORATIVE PSYCHOPHARMACOLOGIC STUDIES EXPLORING CATECHOLAMINE METABOLISM IN PSYCHIATRIC DISORDERS (1974) (26)
Stimulation of adenylate cyclase in rat striatum by pergolide: influence of GTP. (1980) (26)
Neurotensin‐like Peptides in the CNS of Lampreys: Chromatographic Characterization and Immunohistochemical Localization with Reference to Aminergic Markers (1990) (26)
Antiparkinsonian drugs and central dopamine neurons. (1970) (26)
Immunohistochemical studies on phosphorylation of tyrosine hydroxylase in central catecholamine neurons using antibodies raised to phosphorylated forms of the enzyme (1997) (25)
Reduction of adrenaline turnover in cardiovascular areas of rat medulla oblongata by clonidine. (1979) (25)
The effects of Ca++ ions on the C14-catecholamine biosynthesis from C14-tyrosine in slices from the striatum of rats. (1970) (25)
Action of m-tyrosine in experimental models: evidence for possible antiparkinsonian activity. (1973) (25)
Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum. (1990) (25)
NEW DEVELOPMENTS IN METABOLISM OF MESCALINE AND RELATED AMINES * (1962) (25)
Further studies on the effects of the GM1 ganglioside on the degenerative and regenerative features of mesostriatal dopamine neurons. (1984) (25)
The effects of disulfiram on the repletion of brain catecholamine stores. (1966) (25)
BIOSYNTHESIS OF NOREPINEPHRINE AND NORSYNEPHRINE IN THE PERFUSED RABBIT HEART. (1963) (25)
Effects of neuropeptide Y on norepinephrine release in hypothalamic slices of spontaneously hypertensive rats. (1990) (24)
Purification and immunochemical characterization of dopamine beta-hydroxylase from human pheochromocytoma. (1976) (24)
The formation in vivo of N-acetyldopamine and N-acetyl-3-methoxydopamine. (1962) (24)
Dopamine receptor binding for agonists and antagonists in thermal exposed membranes. (1979) (24)
Ultrastructural localisation of dopamine-β-hydroxylase in nerve terminals of the rat brain (1977) (24)
Phenolic alcohols in the brain after administration of DOPA-C14 or dopamine-C14. (1963) (24)
A new approach to quantitate the density and antigen contents of high densities of transmitter-identified terminals. Immunocytochemical studies on different types of tyrosine hydroxylaxe immunoreactive nerve terminals in nucleus caudatus putamen of the rat (1982) (24)
Effects of reserpine on phenylethanolamine N-methyltransferase mRNA levels in rat adrenal gland: Role of steroids (1990) (24)
Evidence for crossed catecholaminergic nigrostriatal projections by combining wheat germ agglutinin-horseradish peroxidase retrograde transport and tyrosine hydroxylase immunocytochemistry (1985) (23)
The metabolism of mescaline-14C in rats (1967) (23)
Immunohistochemical studies on phenylethanolamine-N-methyltransferase, dopa-decarboxylase and dopamine-β-hydroxylase (1971) (23)
An assay for dopamine-β-hydroxylase activity in tissues and serum (1971) (23)
Development of the adrenergic phenotype: increase in adrenal messenger RNA coding for phenylethanolamine-N-methyltransferase. (1982) (23)
Evidence for the existence of a population of arcuate neurons costoring choline acetyltransferase and tyrosine hydroxylase immunoreactivities in the male rat (1989) (23)
Comparison of gene expression of the dopamine D-2 receptor and DARPP-32 in rat brain, pituitary and adrenal gland. (1990) (23)
Evidence for the occurrence of an enkephalin-like peptide in adrenaline and noradrenaline neurons of the rat medulla oblongata (2004) (22)
Changes in Adrenal Enzymes synthesizing Catecholamines in Attack Behaviour evoked by Hypothalamic Stimulation in the Cat (1971) (22)
Catecholamine-stimulated cyclic AMP formation in phenylethanolamine n-methyltransferase containing brain stem nuclei of normal rats and of rats with spontaneous genetic hypertension (1980) (22)
A kinetic study of particulate bovine adrenal tyrosine hydroxylase. (1969) (22)
Studies on dopamine-β-hydroxylase in mental disorders (1974) (22)
Appearance of tyrosine hydroxylase, aromatic amino-acid decarboxylase, dopamine β-hydroxylase and phenylethanolamine N-methyltransferase during the ontogenesis of the adrenal medulla (1979) (22)
Medianosomes as integrative units in the external layer of the median eminence. Studies on grf/catecholamine and somatostatin/catecholamine interactions in the hypothalamus of the male rat (1986) (22)
A familial study in serum dopamine‐β‐hydroxylase levels in torsion dystonia (1974) (22)
Effect of harmaline in monkeys with central nervous system lesions. (1970) (22)
The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway (2004) (21)
Combined use of benserazide and carbidopa in Parkinson's disease (1984) (21)
Treatment failures with levodopa in parkinsonism (1972) (21)
A new group of tyrosine hydroxylase-immunoreactive neurons in the cat thalamus (1989) (21)
Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: Selective protection by sulpiride in the striatum (1986) (21)
Tyrosine hydroxylase in human adrenal and pheochromocytoma: localization, kinetics, and catecholamine inhibition. (1972) (21)
PRELIMINARY ESTIMATES OF THE DOPAMINE β‐HYDROXYLASE CONTENT AND ACTIVITY IN PURIFIED NORADRENERGIC VESICLES 1 (1977) (21)
LHRH and catecholamine neuronal systems in the olfactory bulb of the mouse (1986) (21)
The affinities of ergot compounds for dopamine agonist and dopamine antagonist receptor sites. (1980) (21)
The inhibition of norepinephrine and epinephrine synthesis in vitro. (1961) (21)
Dopamine Autoreceptors a Biochemical, Pharmacological, and Morphological Studies (1990) (21)
Studies on central D1 receptors role in volume transmission, neuroendrocrine regulation and release of noradrenaline. (1988) (21)
Conversion of pregnenolone to dehydroepiandrosterone. (1960) (21)
LERGOTRILE IN PARKINSON'S DISEASE (1976) (20)
D-1 and D-2 Agonists in Parkinson's Disease (1987) (20)
Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas. (1998) (20)
ADRENERGIC CONTROL OF SEROTONIN RELEASE FROM A MIDGUT CARCINOID TUMOUR (1985) (20)
Bromocriptine, lergotrile: the antiparkinsonian efficacy and the interaction with monoaminergic receptors. (1978) (20)
Calcitonin Gene‐Related Peptide in Noradrenergic Transmission in Rat Hypothalamus (1992) (20)
Monoaminergic and Peptidergic Innervation of the Intermedio‐Lateral Horn of the Spinal Cord (1990) (20)
Reversible parkinsonism related to meperidine. (1985) (20)
CEREBRAL METABOLISM OF DOPA-C14 IN RATS. (1964) (20)
A new methodological approach for studying axonal transport: cytofluorometric scanning of nerves. (1984) (19)
Frontiers in Neuropsychiatric Research (1983) (19)
Glucocorticoid regulation of phenylethanolamine N-methyltransferase (PNMT) in organ culture of superior cervical ganglia. (1984) (19)
Tyrosine Hydroxylase mRNA Expression by Dopaminergic Neurons in Culture: Effect of 1 ‐Methyl‐4‐Phenylpyridinium Treatment (1991) (19)
Drug-induced Relief of the Tremor in Monkeys with Mesencephalic Lesions (1969) (19)
Long‐term treatment with pergolide (1984) (19)
Aspects on the Integrative Capabilities of the Central Nervous System: Evidence for ‘Volume Transmission’ and its Possible Relevance for Receptor-Receptor Interactions (1987) (18)
Chronic treatment with 1-dopa plus carbidopa in hemitransected rats: preferential effects at intact dopamine synapses leading to behavioural signs of dopamine receptor supersensitivity. (1983) (18)
Intracisternal administration of cholecystokinin-8 counteracts the central cardiovascular effects of adrenaline and NPY. A study based on the coexistence of cholecystokinin, phenylethanolamine N-methyltransferase and neuropeptide Y immunoreactivity in neurons of the nucleus tractus solitarius (1987) (18)
Antiserum raised against residues 159-168 of the guanine nucleotide-binding protein Gi3-alpha reacts with ependymal cells and some neurons in the rat brain containing cholecystokinin- or cholecystokinin- and tyrosine 3-hydroxylase-like immunoreactivities. (1988) (18)
Intranigral substance P stimulation of striatal dopamine release is inhibited by Spantide II: a new tachykinin antagonist without apparent neurotoxicity (1990) (18)
Immunohistochemical studies on phosphorylation of tyrosine hydroxylase in central catecholamine neurons using site- and phosphorylation state-specific antibodies. (1998) (18)
The postnatal development of tyrosine hydroxylase immunoreactive nerves in rat atrium, studied with immunofluorescence and confocal laser scanning microscopy. (1993) (18)
Regeneration in the central nervous system: concepts and facts. (1988) (17)
The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease. (1985) (16)
Antibodies to a Segment of Tyrosine Hydroxylase Phosphorylated at Serine 40 (1995) (16)
Reserpine-induced effects in the adrenergic neuron as studied with cytofluorimetric scanning (1986) (16)
Differential and independent manifestation within co-containing neurones of neuropeptide Y and tyrosine hydroxylase during ontogeny of the rat central nervous system (1984) (16)
Alterations in dopamine receptors: effect of lesion and haloperidol treatment. (1980) (16)
Alterations in catecholamine release in the central nervous system of spontaneously hypertensive rats. (1991) (16)
MAPPING AND RELATIONSHIP OF HYPOTHALAMIC NEUROTRANSMITTERS AND HYPOTHALAMIC HORMONES (1976) (16)
THE ROLE OF CENTRAL CATECHOLAMINE PATHWAYS IN SPONTANEOUS AND RENAL HYPERTENSION IN RATS (1980) (16)
Interactions of imipramine and synthesis inhibitors on biogenic amines (1974) (16)
EFFECTS OF BRADYKININ ON [3H]‐NOREPINEPHRINE RELEASE IN RAT HYPOTHALAMUS (1993) (16)
D1 receptor mechanisms in the median eminence and their inhibitory regulation of LHRH release (1988) (15)
Ephemeral existence of a single catecholamine synthetic enzyme in the olfactory placode and the spinal cord of the embryonic rat (1985) (15)
Modification of involuntary movements by centrally acting drugs. (1975) (15)
Serum dopamine-Β-hydroxylase (DΒH) activity and affective states (2004) (15)
Phenylethanolamine N-methyltransferase-like immunoreactivity in psoriasis. An immunohistochemical study on catecholamine synthesizing enzymes and neuropeptides of the skin. (1987) (15)
Neuropeptides and classical transmitters. Localization and interaction. (1992) (15)
The innervation of intraocular spinal cord transplants by cografts of locus ceruleus and substantia nigra neurons. (1987) (15)
The therapeutic potential of centrally acting dopamine agonists (1984) (15)
Treatment of advanced Parkinson's disease with dopamine agonists (1981) (15)
Glutamatergic regulation of [3H]-noradrenaline release in the medulla oblongata of normotensive and spontaneously hypertensive rats (1994) (15)
Treatment of Parkinson's disease with lergotrile mesylate. (1977) (15)
The inhibition of tyrosine hydroxylase by 4-isopropyltropolone. (1967) (15)
Inhibition of dopaminc β-oxidase by imipramine (1961) (14)
Serum dopamine-beta-hydroxylase in familial dysautonomia. (1975) (14)
Treatment of Parkinson's disease with dopamine agonists: A review (1979) (14)
A morphometric analysis of transmitter identified dendrites and nerve terminals (1982) (14)
Purification and Characterization of Rat Pheochromocytoma Dopamine β‐Hydroxylase (1980) (14)
Subcellular Site of Biosynthesis of the Catecholamine Biosynthetic Enzymes in Bovine Adrenal Medulla (1984) (14)
Development of Quantitative Methods for the Evaluation of the Entity of Coexistence of Neuroactive Substances in Nerve Terminal Populations in Discrete Areas of the Central Nervous System: Evidence for Hormonal Regulation of Cotransmission (1985) (14)
Effects of antibodies against acetylcholinesterase on the expression of peptides and catecholamine synthesizing enzymes in the rat adrenal gland (1993) (14)
Effect of dopamine-beta-hydroxylase inhibition on cerebral vasospasm in the cat. (1976) (14)
Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum. (1989) (13)
Abundance in the Embryonic Brainstem of Adrenaline During the Absence of Detectable Tyrosine Hydroxylase Activity (1987) (13)
Mapping of central monoamine neurons in the monkey (1972) (13)
DISTRIBUTION AND CHARACTERIZATION OF PNMT AND EPINEPHRINE IN THE CNS (1980) (13)
Chronic immobilization stress: evidence for decreases of 5-hydroxy-tryptamine immunoreactivity and for increases of glucocorticoid receptor immunoreactivity in various brain regions of the male rat (1989) (13)
Photoaffinity labeling and purification of solubilized D2 dopamine receptors. (1985) (13)
Presence of cholecystokinin mRNA in dopamine cells in the ventral mesencephalon of a human with schizophrenia. (1989) (13)
Antibodies to a Synthetic Peptide Corresponding to a Ser‐40‐Containing Segment of Tyrosine Hydroxylase: Activation and Immunohistochemical Localization of Tyrosine Hydroxylase (1989) (13)
Formation of a New Metabolite of Epinephrine and Norepinephrine in Liver and Kidney (1960) (13)
Neuropeptide Y (NPY)-like immunoreactivity in guinea pig uterus is reduced during pregnancy in parallel with noradrenergic nerves (2004) (13)
Regional distribution and metabolism of H3-tyramine in the rat brain. (1970) (13)
Morphometrical and Microdensitometrical Studies on Monoaminergic and Peptidergic Neurons in the Aging Brain (1985) (12)
Modulation of noradrenergic transmission by neuropeptide Y and presynaptic alpha 2-adrenergic receptors in the hypothalamus of spontaneously hypertensive rats. (1992) (12)
Inhibition of PNMT activity in the adrenal glands and brain stem of rats. (1976) (12)
The effects of pergolide on the cardiovascular system of 40 patients with Parkinson's disease. (1983) (12)
The effects of ventrolateral thalamic lesions on tremor and the biosynthesis of dopamine in monkeys with lesions in the ventromedial tegmentum. (1969) (12)
The interactions of bromocriptine and lergotrile with dopamine and α-adrenergic receptors (2005) (12)
Role of Monoamines in the Control of Gonadotrophin Secretion1 (1976) (12)
Chemical Neuroanatomy of the Hypothalamo-Pituitary Axis: Focus on Multimessenger Systems (1987) (11)
The characterization of a new metabolite of dopamine. (1960) (11)
Effects of calcitonin gene-related peptide on [3H]norepinephrine release in medulla oblongata of spontaneously hypertensive rats. (1990) (11)
THE DOPAMINEPHILLIC PROPERTIES OF ERGOLINE DERIVATIVES (1979) (11)
Experimental and clinical studies on bromocriptine in the Parkinsonian syndrome. (1978) (11)
Immunocytochemical studies on axonal transport in adrenergic and cholinergic nerves using cytofluorimetric scanning. (1986) (11)
Neurotransmitters and Neuropeptides: Distribution Patterns and Cellular Localization as Revealed by Immunocytochemistry (1979) (11)
A method for the separation and estimation of catechol amines in urine (1959) (11)
IMMUNOCYTOCHEMICAL STUDIES ON CATECHOLAMINE CELL SYSTEMS WITH ASPECTS ON RELATIONS TO PUTATIVE PEPTIDE TRANSMITTERS (1979) (11)
Neuropeptide Y, peptide YY, and sympathetic control of rectal tone and anal canal pressure in the cat. (1989) (11)
Drug induced changes of abnormal movements in monkeys with central nervous system lesions. (1969) (11)
Serum dopamine-beta-hydroxylase activity in patients with Huntington's chorea and Parkinson's disease. (1972) (11)
Production of involuntary movements by L-dopa in monkeys with tegmental lesions. (1971) (11)
Therapeutic potentials of centrally acting dopamine and alpha 2-adrenoreceptor agonists. (1983) (10)
The effect of GTP on benzodiazepine receptors. (1982) (10)
INHIBITORY EFFECTS OF VERAPAMIL ON [3H]‐ACETYLCHOLINE RELEASE IN THE CENTRAL NERVOUS SYSTEM OF SPRAGUE‐DAWLEY RATS (1994) (10)
Cytofluorimetric scanning: A tool for studying axonal transport in monoaminergic neurons (1982) (10)
Hypothalamic dopamine neurons and hypothalamic peptides. (1977) (10)
Neuropeptide Y and galanin enhance the inhibitory effects of clonidine on norepinephrine release from medulla oblongata of rats. (1990) (10)
Morphometrical analysis of the distribution of luteinizing hormone-releasing hormone and tyrosine hydroxylase-immunoreactive nerve terminals within the lateral palisade zone of the median eminence of the male rat (1983) (10)
Lowering of blood pressure in hypertensive rats by SKF 64139 and SKF 72223. (1982) (10)
Cytofluorimetric Scanning Studies on Axonal Transport in Reserpinized Adrenergic Nerves (1987) (10)
Dopamine agonist potencies of ergolines. (1979) (10)
The regulation of striatal DOPA synthesis by α2-adrenoreceptors (1981) (10)
Serum and tissue dopamine-β-hydroxylase activity in hypophysectomized rats (1973) (10)
Inhibition of endogenous catecholamine biosynthesis by 3-iodo-L-tyrosine. (1965) (9)
Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine. (1978) (9)
Dopamine- and adenosine-3',5'-monophosphate (cAMP)-regulated phosphoprotein of 32 kDa (DARPP-32) in the adrenal gland: immunohistochemical localization. (1991) (9)
Regulatory Mechanisms of Dopamine Biosynthesis at the Tyrosine Hydroxylase Step (1984) (9)
The effect of reduced and oxidized pteridine on dopamine-beta-hydroxylase activity. (1967) (9)
Pergolide and lisuride in advanced Parkinson's disease. (1984) (9)
The metabolism of tyramine-H3 in different regions of the CNS. (1967) (9)
Attempts to combine 2-deoxyglucose autoradiography and tyrosine hydroxylase immunohistochemistry (1984) (9)
Serum dopamine-beta-hydroxylase activity in Down's syndrome: a familial study. (1974) (9)
SYNERGISTIC EFFECTS OF BAY K 8644 AND BRADYKININ ON NOREPINEPHRINE RELEASE IN THE HYPOTHALAMUS OF SPONTANEOUSLY HYPERTENSIVE RATS (1995) (9)
Enzymes Controlling the Biosynthesis of Catecholamines (1966) (9)
MODIFICATION OF THE “ON-OFF” EFFECT WITH BROMOCRIPTINE AND LERGOTRILE (1979) (9)
The pathophysiological functions mediated by D1 dopamine receptors. (1986) (9)
The effect of decortication on the basal ganglia GABA receptor (1980) (8)
Evidence for functional contact between cografted locus coeruleus and spinal cord in oculo: electrophysiological studies (1988) (8)
Further studies with lisuride in Parkinson's disease. (1983) (8)
The Effect of Chronic Nicotine Treatment on 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Degeneration of Nigrostriatal Dopamine Neurons in the Black Mouse (1991) (8)
Growth of human pheochromocytomas in the anterior eye chamber of the rat. A histochemical study on amine and peptide content of pheochromocytoma tumour cells (1986) (8)
EFFECTS OF MONOAMINE OXIDASE INHIBITION ON BIOGENIC AMINE METABOLISM (1963) (8)
Characterization of central neuropeptide Y receptor binding sites and possible interactions with alpha 2-adrenoceptors. (1986) (8)
Relationship between Enzymatic Activity and Oligomerization State of Tyrosine Hydroxylase. (1996) (8)
Hypertrophy of dopamine neurons in the primate following ventromedial mesencephalic tegmentum lesion (2004) (8)
Indirect Evidence of Synthesis of Norepinephrine from 3-Hydroxy-Tyramine-1-C14 in vivo.∗ (1960) (8)
Relatively high levels of dopamine in nucleus accumbens of levodopa treated patients with Parkinson's disease (2005) (8)
Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years. (1980) (8)
The inhibition in vivo of norepinephrine synthesis by adrenalone. (1962) (8)
Characterization, localization and regulation of dopamine-β-hydroxylase and of other catecholamine synthesizing enzymes (1973) (8)
C-fos expression in vivo in human lymphocytes in response to stress (1995) (8)
The effect of DL dopa on harmaline induced tremor and on resting tremor in monkeys with tegmental lesions. (1970) (7)
Effects of chronic uridine treatment on regional neuropeptide and tyrosine hydroxylase-like immunoreactivities in the brain of 12 month-old male rats (1988) (7)
On the Role of Receptor-Receptor Interactions in Synaptic Transmission: Biochemical and Autoradiographical Studies on the Interactions between α2-adrenergic and Neuropeptide Y Receptors in the Nucleus Tractus Solitarius (1987) (7)
The effect of cold pressor test in man on serum immunoreactive dopamine-beta-hydroxylase and on dopamine-beta-hydroxylase activity. (1973) (7)
Induction and reversal of dopamine dyskinesia in rat, cat, and monkey. (1985) (7)
Advances in Biochemical Psychopharmacology vol 1. (1970) (7)
Changes in striatal dopamine neurohistochemistry and biochemistry after incomplete transient cerebral ischemia in the rat (2004) (6)
Delayed appearance of tyrosine hydroxylase-like immunoreactivity in PNMT-immunoreactive neurones of the foetal rat brain. (1984) (6)
Changes in human serum dopamine-β-hydroxylase activity in various physiological and pathological states (1974) (6)
Acute treatment with clozapine blocks D1 dopamine receptor binding in discrete brain areas of the male rat (1989) (6)
The anti-aversive action of minor (1984) (6)
Effects of verapamil on [3H]acetylcholine release in the striatum of spontaneously hypertensive rats. (1992) (6)
Studies on Interactions of Epinephrine Neuronal Systems with other Neuronal Systems (1979) (6)
Drug‐induced relief of experimental tremor in monkeys (1970) (6)
Monkeys with unilateral ventromedial tegmental lesions of the brain stem: Models for parkinson's disease and lesch-nyhan syndrome (1989) (6)
Biochemical aspects of experimentally induced parkinsonism. (1972) (6)
Dopaminergic cells in the caudal A13 cell group express somatostatin-like immunoreactivity (2004) (6)
Intraocular spinal cord grafts: a model system for morphological and functional studies of spinal regeneration. (1988) (6)
Effect of dopaminephilic agents and cAMP on tyrosine hydroxylase activity. (1977) (6)
Histochemistry of Transmitter Interactions - Neuronal Coupling and Coexistence of Transmitters (1979) (6)
Interactions of a partial ergoline with dopamine receptors in vivo and in vitro. (1983) (6)
Human serum dopamine-beta-hydroxylase: relationship to sympathetic activity in physiological and pathological states. (1974) (6)
Recent developments in monoamine histochemistry. (1974) (6)
THE INHIBITION OF DOPAMINE-BETA-HYDROXYLASE BY TROPOLONE AND OTHER CHELATING AGENTS. (1964) (6)
The effect of hyperbaric oxygen on dopaminep-β-hydroxylase activity (1967) (6)
Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor. (1990) (6)
Effect of ventromedial tegmental lesions on central catecholamine neurons of monkey brain: involvement of dopamine pathways in tremor and involuntary movements. (1974) (6)
Management of Levodopa Failures: The Use of Dopamine Agonists (1986) (6)
Olfactory bulb dopamine neurons - the A15 catecholamine cell group. (1977) (5)
Evidence for discrete alterations in central cardiovascular catecholamine and neuropeptide Y immunoreactive neurons in aged male rats and in genetically hypertensive male rats of the Lyon strain. (1987) (5)
New Aspects on the Catecholamine Innervation of the Hypothalamus and the Limbic System (1974) (5)
Adrenal medullary transplants as a treatment for advanced Parkinson's disease (1989) (5)
Generalized presence of a PEC-60-like peptide in catecholamine neurones. (1994) (5)
Update on Bromocriptine in Parkinson's Disease (1989) (5)
Effects of Chronic GM1 Ganglioside Treatment on Nigral Dopamine Cell Bodies and Dendrites in Experimental Rats Using Image Analysis — Relationship to the Pharmacokinetic Properties (1985) (5)
The antiparkinsonian activity of dopamine agonists and their interaction with central dopamine receptor subtypes. (1990) (5)
An assay for dopamine-beta-hydroxylase activity in tissues and serum. (1971) (5)
A familial study in serum dopamine-beta-hydroxylase levels in torsion dystonia. (1974) (5)
Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro. (1985) (5)
Distribution and properties of PNMT in the brain of various mammalian species. (1976) (5)
Galanin-, neuropeptide Y- and enkephalin-like immunoreactivities in catecholamine-storing paraganglia of the fetal guinea pig and newborn pig (1989) (5)
CAPTOPRIL INHIBITS BOTH DOPAMINERGIC AND CHOLINERGIC NEUROTRANSMISSION IN THE CENTRAL NERVOUS SYSTEM (1998) (5)
Effects of pertussis toxin on inhibition of synaptosomal tyrosine hydroxylase activity by apomorphine. (1990) (5)
Effects of Bay K 8644, a Ca2+ channel agonist, on [3H]norepinephrine release in hypothalamus of spontaneously hypertensive rats. (1991) (5)
Regulatory Mechanisms of Dopamine Biosynthesis at the Tyrosine Hydroxylase Step a (1984) (5)
Human fetal catecholamine-containing tissues grafted intraocularly and intracranially to immuno-compromised rodent hosts. (1988) (5)
Studies on the antiparkinsonism efficacy of lergotrile. (1975) (5)
Proceedings: Drugs, mood, and amines: a profile in psychobiological research. (1974) (4)
DISTRIBUTION OF ADRENALINE NEURONS IN THE RAT BRAIN (1984) (4)
EFFECTS OF VERAPAMIL AND DILTIAZEM ON DOPAMINE RELEASE IN THE CENTRAL NERVOUS SYSTEM OF SPONTANEOUSLY HYPERTENSIVE RATS (1993) (4)
Serum Dopamine-β-Hydroxylase Activity in patients with leukemia and in patients with hepatoma (1973) (4)
EFFECT OF DBH- AND PNMT-INHIBITION ON BRAIN ADRENALINE AND NORADRENALINE IN ANIMALS EXPOSED TO STRESS (1980) (4)
The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors. (1977) (4)
A radioimmunoassay of human circulatory dopamine-beta-hydroxylase. (1973) (4)
CHANGES IN CATECHOLAMINE SYNTHESIZING ENZYME ACTIVITIES DURING NEURONAL GROWTH AND DEGENERATION (1974) (4)
Mechanisms involved in the control of extrapyramidal dysfunctions and in striatal dopamine synthesis. (1974) (4)
Inhibition of Dopamine β Oxidase by Adrenalone (1961) (4)
A radioassay for dopamine-β-hydroxylase activity (1965) (4)
Central dopamine agonist activity on the 8-α-amino-ergoline CU 32-085 (1985) (4)
The effect of ventromedial tegmental lesions on the disposition and biosynthesis of dopamine and serotonin. (1974) (3)
Facilitatory effects of diltiazem on dopamine release in the central nervous system. Focus on interactions with D2 autoreceptors and guanosine triphosphate binding proteins. (1992) (3)
DOPAMINE AGONISTS IN PARKINSON'S DISEASE: (1984) (3)
Effect of GABA and benzodiazepine antagonists on [3H]flunitrazepam binding to cerebral cortical membrane (1983) (3)
Distribution of opioidergic, sympathetic and neuropeptide Y-positive nerves in the sphincter of Oddi and biliary tree of the monkey, Macaca fascicularis (1991) (3)
Acetylcholinesterase content of the basal ganglia in monkeys with tegmental lesions. (1970) (3)
EFFECTS OF DILTIAZEM ON [3H]‐ACETYLCHOLINE RELEASE IN RAT CENTRAL NERVOUS SYSTEM (1994) (3)
The involvement of sulfhydryl sites in dopamine-β-hydroxylase activity (1963) (3)
Monkeys with nigrostriatal lesions effects of monoaminergic drugs. (1976) (3)
Central D1 Dopamine Receptors (1988) (3)
COMPLEXITY OF HUMAN MESENCEPHALIC CATECHOLAMINE NEURONS AND SUBSTANCE P TERMINALS: CHANGES IN DISEASE (1982) (3)
Studies on catecholamine-synthesizing enzymes (1990) (3)
Greater calmodulin-dependent regulation of neurotransmitter release and vascular responsiveness in chronic Doca-salt hypertension. (1989) (3)
Ventrolateral thalamic lesions. The effect on striatal amines in the monkey. (1969) (3)
Lesions of the nigro-striatal dopamine pathway: effects on the storage and metabolism of striatal dopamine. (1976) (3)
Activation of α2-adrenoreceptors enhances haloperidol-induced suppression of operant behavior (2005) (3)
Chapter 74 Adrenal medullary transplants as a treatment for advanced Parkinson's disease (1990) (3)
Serum dopamine-beta-hydroxylase levels in Down's syndrome. (1974) (3)
EFFECTS OF CAPTOPRIL ON [3H]‐NOREPINEPHRINE RELEASE IN RAT CENTRAL NERVOUS SYSTEM (1995) (3)
The metabolism of mescaline-14-C in rats. (1967) (3)
Sodium ions attenuate the inhibitory effects of neuropeptide Y on norepinephrine release in rat hypothalamus. (1995) (3)
MAMMALIAN 3-BETA-HYDROXYSTEROID DEHYDROGENASE SYSTEMS. (1965) (2)
Related Responses Between Dopamine Synapses and Astrocytes in the Rat Striatum After Global Cerebral Ischemia: A Morphometric and Microdensitometric Study (1989) (2)
Dyskinesia induced by long-term treatment with antipsychotic drugs: involvement of pre- and postsynaptic dopaminergic mechanisms. (1980) (2)
Central dopamine agonist activity on the 8-alpha-amino-ergoline CU 32-085. (1985) (2)
Studies on dopamine-beta-hydroxylase in mental disorders. (1974) (2)
The synthesis of NPY and DBH is independently regulated in adrenergic nerves after reserpine (1987) (2)
Studies on enzymicβ-hydroxylation of phenylethyl amines (1961) (2)
Dopamine-beta-hydroxylase in experimental spinal cord injury. (1973) (2)
The Therapeutic Potential of D1 and D2 Dopamine Agonists in Parkinson’S Disease (1988) (2)
The specificity and cellular origin of phenylethanolamine N‐methyltransferase (PNMT)‐like immunoreactivity in psoriatic skin (1990) (2)
STUDIES ON DOPAMINE-β-HYDROXYLASE IN MENTAL DISORDERS* (1975) (2)
Cardiovascular Activity of SK&F 64139 in the Hypertensive Rat (1983) (2)
IMMUNOHISTOCHEMISTRY OF TYROSINE HYDROXYLASE (TH) IN HUMAN AND SIMIAN NERVOUS SYSTEMS: ALTERATIONS IN FAMILIAL DYSAUTONOMIA (1979) (2)
PEC-60 AND RELATED PEPTIDES AS HORMONES IN THE GASTROINTESTINAL TRACT AND THE IMMUNE SYSTEM AND AS GENERALIZED COTRANSMITTERS IN CATECHOLAMINE NEURONS (1994) (2)
Ergot alkaloids and central monoaminergic receptors. (1985) (2)
Inhibition of dopamine beta-oxidase by imipramine. (1961) (2)
Characterization of Striatal Ibotenate Lesions and of 6-Hydroxydopamine Induced Nigral Lesions by Morphometric and Densitometric Approaches (1983) (2)
EVIDENCE FOR STRUCTURAL PLASTICITY IN THE NIGROSTRIATAL DOPAMINE NEURONS: MORPHOMETRICAL AND BIOCHEMICAL EVIDENCE FOR A TROPHIC ACTION OF GANGLIOSIDES ON PARTIALLY LESIONED NIGROSTRIATAL DOPAMINE NEURONS (1984) (2)
Advanced Parkinson's disease (1987) (2)
ON THE ROLE OF NORADRENALINE AND ADRENALINE NEURON SYSTEMS IN CONTROL OF CENTRAL CARDIOVASCULAR FUNCTIONS (1979) (2)
Goldstein et al. reply (1986) (2)
Pheochromocytoma: an animal model. (1980) (2)
The alteration of catecholamine metabolism by tropolone in vivo (1962) (2)
Proceedings: Human serum dopamine-beta-hydroxylase: relationship to sympathetic activity in physiological and pathological states. (1974) (2)
The MPTP Model of Parkinson's Disease in the Mouse. Modafinil—a New Potential Neuroprotective Agent (1994) (2)
Ontogenetic appearance and disappearance of tyrosine hydroxylase (2)
Long-lasting anti-tremor induced by 2-Br-alpha-ergocryptine in monkeys. (1974) (2)
The regulation of striatal DOPA synthesis by alpha 2-adrenoreceptors. (1981) (2)
Comparative efficacy of two dopamine agonists, pergolide and lergotrile, in Parkinson disease. (1988) (2)
The blockade of alpha 2-adrenoceptors by the PNMT inhibitaor SK&F 64139. (1980) (2)
Topographic Distribution of Catecholaminergic Neurons in the Rat Medulla Oblongata Using Quantitative Three-Dimensional Reconstruction (1985) (2)
CATECHOLAMINE-STIMULATED CYCLIC AMP FORMATION IN BRAINSTEM NUCLEI OF NORMAL RATS AND RATS WITH GENETIC HYPERTENSION (1980) (2)
PHENYLETHANOLAMINE-N-METHYLTRANSFERASE AND EPINEPHRINE IN THE BRAIN (1979) (2)
Mesulergine: a dopamine agonist with novel properties in Parkinson's disease. (1990) (2)
The relative metabolic rates of norepinephrine-7-H3 and epinephrine-1-C14 (1960) (2)
Morphological and Biochemical Studies on Neuropeptide Y (NPY) and Adrenergic Mechanisms and their Interactions in Central Cardiovascular Regulation (1986) (1)
Antiserum raised against residues 159-168 of the guanine nucleotide-binding protein GM 3-a reacts with ependymal cells and some neurons in the rat brain containing cholecystokinin-or cholecystokinin-and tyrosine 3-hydroxylase-like immunoreactivities ( transduction / glial cells / dopamine / neuropep (1)
Activation of rat pheochromocytoma tyrosine hydroxylase by a cyclic AMP-dependent protein kinase in a cell-free system (2005) (1)
A novel method for rapid enrichment of lactotrophs from dispersed anterior pituitary cells of the rat. (1993) (1)
Neurotransmitter related immunocytochemistry of the human central nervous system. (1983) (1)
Biochemical and functional characterization of central dopamine receptors. (1988) (1)
THE ANTIPARKINSONIAN EFFICACY AND DOPAMINERPHILLIC PROPERTIES OF ERGOT ALKALOIDS AND OF TETRAHYDROISOQUINOLINES (1979) (1)
541 Inhibition of dopamine β-oxidase by amphetamine and p-hydroxyamphetamine (1961) (1)
The metabolism of tvramine-H3 in different regions of the CNS -hvdroxylase inhibition on its metabolism in rat brain (1967) (1)
Adrenal medullary transplants as a treatment for Parkinson's disease. (1990) (1)
Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist. (1981) (1)
Subject Index Vol. 16 (suppl 1), 1978 (1978) (1)
Central D[1] dopamine receptors (1988) (1)
12. Dyskinesia Produced by L-Dopa in Monkeys with Tegmental Lesions and Resting Tremor (1973) (1)
Further studies with lisuride a potent dopamine and serotonin agonist in patients with parkinson disease who are no longer satisfactorily responding to l dopa (1981) (1)
Activation of alpha 2-adrenoreceptors enhances haloperidol-induced suppression of operant behavior. (1986) (1)
Multiple Forms of Dopamine β‐Hydroxylase in Rat Brain (1986) (1)
The effect of butaclamol and of other neuroleptic agents on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity. (1975) (1)
RAT PHEOCHROMOCYTOMA TYROSINE HYDROXYLASE AND DOPAMINE β HYDROXYLASE: PURIFICATION AND CHARACTERIZATION (1979) (1)
The metabolism of 3-hydroxytyramine-1-C14 in brain tissue homogenates (1959) (1)
Expression of tyrosine hydroxylase-like immunoreactivity in cell bodies in intraocular spinal cord grafts: a comparison with classical Falck-Hillarp histochemistry. (1990) (1)
Studies on inhibition of 3,4-dihydrophenylethylamine (dopamine) β-oxidasein vitro (1961) (1)
Inhibition of dopamine beta oxidase by adrenalone. (1961) (1)
Studies on inhibition 3, 4-dihydrophenylethylamine (dopamine) beta-oxidase in vitro. (1961) (1)
Bromocriptine and Lergotrile in Parkinson Disease (1979) (1)
The effect of various chlorpromazine derivatives on the apomorphine-elicited inhibition of synaptosomal tyrosine hydroxylase activity. (1975) (1)
Further studies on dopamine-beta-hydroxylase in neuroblastoma. Abstr. (1973) (1)
Histochemical Mapping of Dopamine Neurons in the Olfactory Brain (1980) (1)
Purification and characterization of rat pheochromocytoma dopamine beta-hydroxylase. (1980) (0)
The activation and inhibition of phenylamine-β-hydroxylase (1962) (0)
Effects of excitatory amino acids on norepinephrine release in the central nervous system of hypertension (1994) (0)
Dopamine Receptors: Antiparkinsonian Activity and Molecular Mechanisms (1985) (0)
INFLUENCE OF THE SUBSTANTIA NIGRA ON THE SYNTHESIS OF BIOGENIC AMINES IN THE STRIATUM (1969) (0)
Catecholamine synthesizing enzymes in rat pheochromocytoma PC-12 cells (1981) (0)
The Evaluation of Antiparkinsonian Activities in Primate Models of Parkinsonism (1994) (0)
THE INVOLVEMENT OF SULFHYDRYL SITES IN DOPAMINE-BETA-HYDROXYLASE ACTIVITY. (1963) (0)
Transplantation of Human Dopaminergic Neurons in Parkinsonism: Experimental Reality and Future Clinical Feasibility (1988) (0)
A6 The role of protein kinase C in the regulation of neurotransmitter release in the central nervous system of spontaneously hypertensive rats (1997) (0)
330 – MAPPING AND RELATIONSHIP OF BRAIN NEUROTRANSMITTERS AND THE HYPOTHALAMIC RELEASING HORMONES (1977) (0)
INITIAL APPEARANCE OF THE NORADRENERGIC PHENOTYPE IN NEUROBLASTS OF THE RAT EMBRYO (1979) (0)
Formation of norepinephrine from tyrosine in isolated rabbit heart (1963) (0)
Contents, Supplement 1, 1978 (1978) (0)
THE STEREOSPECIFICITY OF THE ENZYMATIC AMPHETAMINE BETA-HYDROXYLATION. (1964) (0)
The inhibition of tyrosine hydroxylase by 4 iso propyl tropolone in vivo and in vitro (1968) (0)
Distribution of PNMT and Epinephrine in the medulla oblongata of normotensive and spontaneous hypertensive rats (2005) (0)
Regulation of dopa biosynthesis by presynaptic dopamine receptors and ∝ 2 - adrenoreceptors (1981) (0)
[Role of adrenalin in hyperthyroidism]. (1956) (0)
1298 – COMPARATIVE STUDIES ON SYNAPTOSOMAL TYROSINE HYDROXYLASE FROM THE STRIATUM AND MESOLIMBIC SYSTEMS: STIMULATION BY DIBUTYRYL CYCLIC AMP AND INHIBITION BY APOMORPHINE (1977) (0)
[Participation of adrenalin and its derivatives in the specific-dynamic effect of proteins in humans]. (1955) (0)
Letter to the Editor Serum Dopamine- B-Hydroxylase Activity in Patients with Leukemia and in Patients with Hepatoma* (1973) (0)
HUMAN NEUROTRANSMITTER SYNTHETIC ENZYME HISTOCHEMISTRY IN NORMAL AND DISEASED AUTOPSY TISSUE (1978) (0)
Dopamine synthesis and release in AtT20 cells expressing recombinant tyrosine hydroxylase (TH) (1998) (0)
Serum Dopamine-β-Hydroxylase in Various Pathological States (1975) (0)
136 CEREBELLAR “NEUROBLASTOMA” AND ITS RELATIONSHIP TO MEDULLOBLASTOMA (1980) (0)
Repopulation of central α2-adrenoreceptors (1985) (0)
Monoaminergic enzymes other than MAO. (1974) (0)
On effects of an angiotensin converting enzyme inhibitor, Captopril on norepinephrine release in central neuron. (1993) (0)
The effect of pH on enzymatic formation and inhibition of norepinephrine synthesis (1962) (0)
Basic aspects of receptor biochemistry. Proceedings of the international symposium, Vienna, September 10-12, 1982. (1983) (0)
Role of biogenic amines in the central nervous system. (1975) (0)
[The role of adrenalin, noradrenalin and oxytyramine in the specifically dynamic action of protein and amino acids]. (1957) (0)
A radioassay for dopamine-beta-hydroxylase activity. (1965) (0)
Hybrid histochemical localization of tyrosine hydroxylase mRNA in the CNS (1986) (0)
Letter: Serum dopamine-beta-hydroxylase activity in patients with leukemia and in patients with hepatoma. (1973) (0)
Studies on enzymic beta-hydroxylation of phenyl-ethyl amines. (1961) (0)
Studies on the regional biosynthesis and metabolism of catecholamines in the central nervous system of the monkey (1967) (0)
EFFECTS OF DILTIAZEM ON DOPAMINE RELEASE IN THE CENTRAL NERVOUS SYSTEM OF SPONTANEOUSLY HYPERTENSIVE RATS (1993) (0)
Mesulergine ce 32 085 in parkinsons disease (1984) (0)
The effect of hyperbaric oxygen on dopamine-beta-hydroxylase activity. (1967) (0)
NERVE TERMINALS IN SAMPLED REGIONS. STUDIES ON TYROSINE HYDROXYLASE LHRH, TRH AND GIH (1977) (0)
THE ROLE OF NEUROPEPTIDE Y IN THE REGULATION OF NORADRENERGIC TRANSMISSION IN HYPOTHALAMUS OF SPONTANEOUSLY HYPERTENSIVE RATS (1991) (0)
A radioimmunoassay for dopamine-β-hydroxylase using a glass-bound antibody (1974) (0)
The differences in the accumulation and metabolism of catechol amines in heart and liver (1960) (0)
Regulation of tyrosine hydroxylase mRNA levels by cell-cell contact in cultured PC12 cells (1987) (0)
The part played by adrenaline and its derivatives in the specific dynamic action of protein in man. (1955) (0)
A double-blind comparative trial of oxaprotiline with amitriptyline and placebo in outpatients with moderate depression: relationship of urinary MHPG levels (1983) (0)
Adrenal medullary transplants as a treatment for advanced Parkinson's disease. (1989) (0)
2730 – INTERDEPENDENCE OF NEUROTRANSMITTERS AND NEUROTRANSMITTER SYSTEMS - MORPHOLOGICAL BASIS (1978) (0)
Occurrence of neuropeptides and growth factors in relation to mesencephalic dopamine neurons (1994) (0)
Serum and tissue dopamine-beta-hydroxylase activity in hypophysectomized rats. (1973) (0)
The activation and inhibition of phenylamine-beta-hydroxylase. (1962) (0)
International Society for research in Stereoencephalotomy (1970) (0)
Subject Index Vol. 57, 1993 (1993) (0)
The possible role of central epinephrine, ∝2-adrenoreceptors and presynaptic dopamine receptors in affective disorders (1983) (0)
The characterization of the dopaminergic profile of EMD 23,448, an indolyl-3-butylamine: Selective actions on presynaptic and supersensitive postsynaptic DA receptor populations (2005) (0)
A radioimmunoassay for dopamine-beta-hydroxylase using a glass-bound antibody. (1974) (0)
[Specific dynamic effect of protein]. (1954) (0)
Effect of ketanserin on central and peripheral sympathetic nerve activity. (1990) (0)
Receptor Reserves at α2-adrenergic and Dopaminergic Autoreceptors (1987) (0)
Antibodies to synthetic peptides corresponding to segments of the dopamine da d 2 receptor (1990) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Menek Goldstein?

Menek Goldstein is affiliated with the following schools: